Does GLATIRAMER Cause Disease progression? 187 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 187 reports of Disease progression have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.4% of all adverse event reports for GLATIRAMER.
187
Reports of Disease progression with GLATIRAMER
0.4%
of all GLATIRAMER reports
4
Deaths
13
Hospitalizations
How Dangerous Is Disease progression From GLATIRAMER?
Of the 187 reports, 4 (2.1%) resulted in death, 13 (7.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 187 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which GLATIRAMER Alternatives Have Lower Disease progression Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE